Detailed price information for Defence Therapeutics Inc (DTC-CN) from The Globe and Mail including charting and trades.

U.S. pharmaceutical companies are stepping up their campaign for higher drug prices in Europe, in some cases threatening to ...

Defence Therapeutics Inc., (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a publicly traded biotechnology company, today ...

AMD researchers argue that, while algorithms like the Ozaki scheme merit investigation, they're still not ready for prime ...

The International Society for Pharmaceutical Engineering (ISPE) has announced the establishment of the ISPE Radiopharmaceuticals Community of Practice (CoP). This initiative is intended to respond to ...

This week, Point Quest Group, a national provider of special education services, training, and program management, looked back on a transformative 2025. While the organization operates at a national ...

Based on the topline results from the EPCORE® DLBCL-1 trial, AbbVie along with partner Genmab will engage global regulatory authorities to discuss next steps NORTH ...

Society for Science (the Society) announced the top 300 scholars in the Regeneron Science Talent Search 2026, the nation’s ...

Orbis Investment Management released its Q4 2025 investor letter for “Orbis SICAV International Equity Fund”. The Strategy reported a positive year in 2025, with returns driven more by stock-specific ...

Hydrogels are among the most widely studied biomaterials in modern drug delivery research. Their high hydrophilicity, ...